{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T21:44:54Z","timestamp":1783115094545,"version":"3.54.6"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,11,30]]},"DOI":"10.7759\/cureus.20035","type":"journal-article","created":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T17:33:51Z","timestamp":1638293631000},"source":"Crossref","is-referenced-by-count":5,"title":["A Rare Case of Delayed Onset Multi-Drug Interaction Resulting in Rhabdomyolysis in a 66-Year-Old Male"],"prefix":"10.7759","author":[{"given":"Harmony","family":"Osborn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Grossman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smriti","family":"Kochhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anish","family":"Kanukuntla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyaranjan","family":"Kata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pramil","family":"Cheriyath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.4103\/picr.PICR_132_16","article-title":"A study of harmful drug-drug interactions due to polypharmacy in hospitalized patients in Goa Medical College","volume":"8","author":"Khandeparkar A","year":"2017","unstructured":"Khandeparkar A, Rataboli PV. A study of harmful drug-drug interactions due to polypharmacy in hospitalized patients in Goa Medical College. Perspect Clin Res. 2017, 8:180-186. 10.4103\/picr.PICR_132_16","journal-title":"Perspect Clin Res"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.6515\/acs20160611a","article-title":"Statin therapy: review of safety and potential side effects","volume":"32","author":"Ramkumar S","year":"2016","unstructured":"Ramkumar S, Raghunath A, Raghunath S. Statin therapy: review of safety and potential side effects. Acta Cardiol Sin. 2016, 32:631-639. 10.6515\/acs20160611a","journal-title":"Acta Cardiol Sin"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.2000.00134.x","article-title":"Inhibitory effects of amiodarone and its N-deethylated metabolite on human cytochrome P450 activities: prediction of in vivo drug interactions","volume":"49","author":"Ohyama K","year":"2000","unstructured":"Ohyama K, Nakajima M, Suzuki M, Shimada N, Yamazaki H, Yokoi T. Inhibitory effects of amiodarone and its N-deethylated metabolite on human cytochrome P450 activities: prediction of in vivo drug interactions. Br J Clin Pharmacol. 2000, 49:244-253. 10.1046\/j.1365-2125.2000.00134.x","journal-title":"Br J Clin Pharmacol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/bcpt.13035","article-title":"Rosuvastatin-induced rhabdomyolysis - possible role of ticagrelor and patients' pharmacogenetic profile","volume":"123","author":"Vrki\u0107 Kirhmajer M","year":"2018","unstructured":"Vrki\u0107 Kirhmajer M, Macoli\u0107 \u0160arini\u0107 V, \u0160imi\u010devi\u0107 L, Ladi\u0107 I, Putarek K, Banfi\u0107 L, Bo\u017eina N. Rosuvastatin-induced rhabdomyolysis - possible role of ticagrelor and patients' pharmacogenetic profile. Basic Clin Pharmacol Toxicol. 2018, 123:509-518. 10.1111\/bcpt.13035","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2014.41","article-title":"Genetic factors affecting statin concentrations and subsequent myopathy: a HuGENet systematic review","volume":"16","author":"Canestaro WJ","year":"2014","unstructured":"Canestaro WJ, Austin MA, Thummel KE. Genetic factors affecting statin concentrations and subsequent myopathy: a HuGENet systematic review. Genet Med. 2014, 16:810-819. 10.1038\/gim.2014.41","journal-title":"Genet Med"},{"key":"ref6","article-title":"Brilinta\u2122 (ticagrelor) tablets: a P2Y12 platelet inhibitor indicated to reduce the rate of thrombotic cardiovascular events in patients with acute coronary syndrome (ACS)","volume":"37","year":"2012","unstructured":"Brilinta\u2122 (ticagrelor) tablets. a P2Y12 platelet inhibitor indicated to reduce the rate of thrombotic cardiovascular events in patients with acute coronary syndrome (ACS). P T. 2012, 37:4-18.","journal-title":"P T"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.165.22.2671","article-title":"Outcomes in 45 patients with statin-associated myopathy","volume":"165","author":"Hansen KE","year":"2005","unstructured":"Hansen KE, Hildebrand JP, Ferguson EE, Stein JH. Outcomes in 45 patients with statin-associated myopathy. Arch Intern Med. 2005, 165:2671-2676. 10.1001\/archinte.165.22.2671","journal-title":"Arch Intern Med"},{"key":"ref8","article-title":"Acute kidney injury due to rhabdomyolysis","volume":"19","author":"Lima RS","year":"2008","unstructured":"Lima RS, da Silva Junior GB, Liborio AB, Daher EF. Acute kidney injury due to rhabdomyolysis. Saudi J Kidney Dis Transpl. 2008, 19:721-729.","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/sj.tpj.6500115","article-title":"Differential metabolism of alprazolam by liver and brain cytochrome (P4503A) to pharmacologically active metabolite","volume":"2","author":"Pai HV","year":"2002","unstructured":"Pai HV, Upadhya SC, Chinta SJ, Hegde SN, Ravindranath V. Differential metabolism of alprazolam by liver and brain cytochrome (P4503A) to pharmacologically active metabolite. Pharmacogenomics J. 2002, 2:243-258. 10.1038\/sj.tpj.6500115","journal-title":"Pharmacogenomics J"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.163.6.688","article-title":"Screening for statin-related toxicity: the yield of transaminase and creatine kinase measurements in a primary care setting","volume":"163","author":"Smith CC","year":"2003","unstructured":"Smith CC, Bernstein LI, Davis RB, Rind DM, Shmerling RH. Screening for statin-related toxicity: the yield of transaminase and creatine kinase measurements in a primary care setting. Arch Intern Med. 2003, 163:688-692. 10.1001\/archinte.163.6.688","journal-title":"Arch Intern Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1186\/1476-511X-11-40","article-title":"Statin therapy, myopathy and exercise--a case report","volume":"11","author":"Semple SJ","year":"2012","unstructured":"Semple SJ. Statin therapy, myopathy and exercise--a case report. Lipids Health Dis. 2012, 11:40. 10.1186\/1476-511X-11-40","journal-title":"Lipids Health Dis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/71351-a-rare-case-of-delayed-onset-multi-drug-interaction-resulting-in-rhabdomyolysis-in-a-66-year-old-male","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:32:22Z","timestamp":1707507142000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/71351-a-rare-case-of-delayed-onset-multi-drug-interaction-resulting-in-rhabdomyolysis-in-a-66-year-old-male"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,30]]},"references-count":11,"URL":"https:\/\/doi.org\/10.7759\/cureus.20035","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11,30]]}}}